206 related articles for article (PubMed ID: 32808286)
21. Mohs micrographic surgery concordance between Mohs surgeons and dermatopathologists.
Semkova K; Mallipeddi R; Robson A; Palamaras I
Dermatol Surg; 2013 Nov; 39(11):1648-52. PubMed ID: 24581313
[TBL] [Abstract][Full Text] [Related]
22. Peritumoral fibrosis in basal cell and squamous cell carcinoma mimicking perineural invasion: potential pitfall in Mohs micrographic surgery.
Hassanein AM; Proper SA; Depcik-Smith ND; Flowers FP
Dermatol Surg; 2005 Sep; 31(9 Pt 1):1101-6. PubMed ID: 16164857
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers.
Ebede TL; Lee EH; Dusza SW; Busam KJ; Nehal KS
Dermatol Surg; 2012 Oct; 38(10):1631-8. PubMed ID: 22958072
[TBL] [Abstract][Full Text] [Related]
24. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery.
Veronese F; Farinelli P; Zavattaro E; Zuccoli R; Bonvini D; Leigheb G; Colombo E
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):838-43. PubMed ID: 21707774
[TBL] [Abstract][Full Text] [Related]
25. Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery.
Chuang GS; Lu LK; Cummins DL; Wu H; Finn D; Rogers GS; Lee D
Dermatol Surg; 2012 Sep; 38(9):1456-60. PubMed ID: 22734860
[TBL] [Abstract][Full Text] [Related]
26. Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer -Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.
Miñano Medrano R; López Estebaranz JL; Sanmartin-Jiménez O; Garcés JR; Rodríguez-Prieto MA; Vilarrasa-Rull E; de Eusebio-Murillo E; Escutia-Muñoz B; Flórez-Menéndez Á; Artola-Igarza JL; Alfaro-Rubio A; Redondo P; Delgado-Jiménez Y; Sánchez-Schmidt JM; Allende-Markixana I; Alonso-Pacheco ML; García-Bracamonte B; de la Cueva-Dobao P; Navarro-Tejedor R; Ciudad-Blanco C; Carnero-González L; Vázquez-Veiga H; Cano-Martínez N; Ruiz-Salas V; Sánchez-Sambucety P; Botella-Estrada R; González-Sixto B; Martorell-Calatayud A; Gil P; Morales-Gordillo V; Toll-Abelló A; Ocerin-Guerra I; Mayor-Arenal M; Suárez-Fernández R; Sainz-Gaspar L; Descalzo MA; García-Doval I;
Actas Dermosifiliogr; 2022 May; 113(5):451-458. PubMed ID: 35431059
[TBL] [Abstract][Full Text] [Related]
27. Application of Mohs micrographic surgery appropriate-use criteria to skin cancers at a university health system.
Blechman AB; Patterson JW; Russell MA
J Am Acad Dermatol; 2014 Jul; 71(1):29-35. PubMed ID: 24813300
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis.
Sohn GK; Keniston K; Kannan S; Hinds B; Jian SIB
J Drugs Dermatol; 2021 Aug; 20(8):874-879. PubMed ID: 34397195
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological Factors Influencing Resection Margin Involvement During Mohs Micrographic Surgery for Skin Tumors.
Chu J; Chung Y; Chae SW; Choi YJ; Kim HS; DO SI
Anticancer Res; 2023 Jun; 43(6):2707-2715. PubMed ID: 37247935
[TBL] [Abstract][Full Text] [Related]
30. Solid organ transplant recipients presenting for Mohs micrographic surgery: a retrospective case-control study.
Upjohn E; Bhore R; Taylor RS
Dermatol Surg; 2012 Sep; 38(9):1448-55. PubMed ID: 22587392
[TBL] [Abstract][Full Text] [Related]
31. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
[TBL] [Abstract][Full Text] [Related]
32. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
33. Waiting time for Mohs Micrographic Surgery and the associated increase in lesion size of basal cell carcinoma.
Kokkinos C; Kanapathy M; Heydari S; Hamilton S; Withey S
J Plast Reconstr Aesthet Surg; 2022 Sep; 75(9):3384-3389. PubMed ID: 35794062
[TBL] [Abstract][Full Text] [Related]
34. Basal cell carcinoma histopathologic upgrading and Mohs micrographic surgery: a single institution, retrospective review.
Walocko F; Chelliah P; Kolitz E; Awerman J; Nijhawan RI; Srivastava D
Arch Dermatol Res; 2022 Sep; 314(7):705-707. PubMed ID: 33683445
[TBL] [Abstract][Full Text] [Related]
35. Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane.
Orengo IF; Salasche SJ; Fewkes J; Khan J; Thornby J; Rubin F
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):395-7. PubMed ID: 9308552
[TBL] [Abstract][Full Text] [Related]
36. Reflectance confocal microscopy confirms residual basal cell carcinoma on clinically negative biopsy sites before Mohs micrographic surgery: A prospective study.
Navarrete-Dechent C; Cordova M; Aleissa S; Liopyris K; Dusza SW; Phillips W; Rossi AM; Lee EH; Marghoob AA; Nehal KS
J Am Acad Dermatol; 2019 Aug; 81(2):417-426. PubMed ID: 31227277
[TBL] [Abstract][Full Text] [Related]
37. Mohs Micrographic Surgery at the Skin and Cancer Foundation Australia, 20 Years Later (1997-2017).
Stewart TJ; Moreno Bonilla G; Venning VL; Lee S; Fernandez-Peñas P
Dermatol Surg; 2020 Feb; 46(2):165-168. PubMed ID: 31274529
[TBL] [Abstract][Full Text] [Related]
38. Misclassification of Aggressive Basal Cell Carcinoma Subtypes and Implications for Management.
Moon D; Randall G; Higgins S; Sutton AV; Wysong A
Dermatol Surg; 2021 May; 47(5):593-598. PubMed ID: 33905389
[TBL] [Abstract][Full Text] [Related]
39. Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread.
Hoorens I; Batteauw A; Van Maele G; Lapiere K; Boone B; Ongenae K
Br J Dermatol; 2016 Apr; 174(4):847-52. PubMed ID: 26595159
[TBL] [Abstract][Full Text] [Related]
40. Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria.
Stuart SE; Schoen P; Jin C; Parvataneni R; Arron S; Linos E; Boscardin WJ; Chren MM
J Am Acad Dermatol; 2017 Jun; 76(6):1131-1138.e1. PubMed ID: 28365039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
